RE:RE:RE:RE:RE:Teuto or Verdemed?There is no rush in generating value for shareholders at this point from a really short term perspective. They have a business that is stable balance sheet wise and have cash to last a few years. Whether it happens in 2024, 2025 or 2026 doesn't matter. If they manage to build a good profitable business and they grow revs, market cap will follow.